Expertos Invitados





COMO EVALUAR LOS TRASTORNOS DEL SUEÑO EN LA ENFERMEDAD DE PARKINSON

(especial para SIIC © Derechos reservados)
Existen dos escalas específicas, la Parkinson's Disease Sleep Scale y la SCOPA-Sueño, con propiedades psicométricas adecuadas, para evaluar los trastornos del sueño en la enfermedad de Parkinson.
martinezmartin.jpg Autor:
Pablo Martínez martín
Columnista Experto de SIIC

Institución:
Instituto de Salud Carlos III

Artículos publicados por Pablo Martínez martín
Coautor
Carmen Rodríguez Blázquez* 
Licenciada en Psicología, Instituto de Salud Carlos III, Madrid, España*
Recepción del artículo
15 de Noviembre, 2008 		Aprobación
11 de Diciembre, 2008
Primera edición
20 de Marzo, 2009 		Segunda edición, ampliada y corregida
7 de Junio, 2021

COMO EVALUAR LOS TRASTORNOS DEL SUEÑO EN LA ENFERMEDAD DE PARKINSON

Resumen
En la actualidad existen dos cuestionarios específicos para evaluar los trastornos del sueño de los pacientes con enfermedad de Parkinson: la Escala de Sueño para Enfermedad de Parkinson (Parkinson's Disease Sleep Scale [PDSS]) y la SCOPA-Sueño (Scales for Outcomes in Parkinson's Disease-Sleep). Estas dos escalas tienen, en conjunto, propiedades psicométricas satisfactorias y son de fácil aplicación e interpretación. Debido a su estructura y contenido pueden considerarse complementarias, dado que la PDSS informa más sobre la calidad del sueño nocturno y las causas de su alteración y la SCOPA-Sueño evalúa sueño nocturno y somnolencia diurna, pero no explora los síntomas que influyen en la calidad del sueño nocturno. Otros dos instrumentos específicos para la enfermedad de Parkinson, el Cuestionario y la Escala de Síntomas no motores, se desarrollaron para identificar y cuantificar (respectivamente) dichas manifestaciones. Ambos contienen dominios específicos para trastornos del sueño que, aunque menos extensos y detallados que la PDSS y la SCOPA-Sueño, permiten cuantificarlos simultáneamente (y por tanto, establecer relaciones) con una variedad de alteraciones de enorme interés. Debido a la complejidad de las manifestaciones de la enfermedad de Parkinson, la evaluación del paciente es necesariamente compleja y ha de facilitarse mediante la disponibilidad de instrumentos útiles y válidos.

Palabras clave
trastornos del sueño, enfermedad de Parkinson, escalas, atributos psicométricos


Artículo completo
(castellano)
Extensión:  +/-6.4 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

SLEEP DISORDERS IN PATIENTS WITH PARKINSON'S DISEASE

Abstract
Currently, there are two specific questionnaires for the assessment of sleep disorders in patients with Parkinson's disease: the Parkinson's Disease Sleep Scale (PDSS) and the Scales for Outcomes in Parkinson's Disease-Sleep (SCOPA-Sleep). Both scales have, as a whole, satisfactory psychometric properties; they are easy to apply and to be interpreted. Due to their structure and content, they can be considered complementary since the PDSS mainly informs about the quality of nocturnal sleep and the potential disturbing causes and the SCOPA-Sleep assesses nocturnal sleep and daytime sleepiness, but it does not explore the symptoms that may influence the quality of the nocturnal sleep. Other two specific instruments for Parkinson's disease, the Non-Motor Symptoms Questionnaire and Scale, were developed to identify and to quantify (respectively) this kind of manifestations. Both contain specific domains for sleep dysfunctions that, although less extensive and detailed than the PDSS and the SCOPA-Sleep, allow to assess them simultaneously (and therefore to establish relationships) with a variety of relevant disorders. Due to the complexity of the Parkinson's disease manifestations, patient evaluation is necessarily complex and should be aided with the help of useful and valid instruments.

Key words
sleep disorders, Parkinson's disease, rating scales, psychometric attributes

Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Neurología
Relacionadas: Atención Primaria, Geriatría, Medicina Interna, Salud Mental



Comprar este artículo
Extensión: 6.4 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Pablo Martínez Martín, Instituto de Salud Carlos III Centro Nacional de Epidemiología, 28029, C/ Sinesio Delgado, 6, Madrid, España
Bibliografía del artículo

1. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11:512-519, 1988.
2. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 14:922-927, 1999.
3. Karlsen K, Larsen JP, Tandberg E, Jogersen K. Fatigue in patients with Parkinson's disease. Mov Disord 14:237-241, 1999.
4. Ferreira JJ, Desboeuf K, Galitzky M, Thalamas C, Brefel-Courbon C, Fabre N et al. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol 13:209-214, 2006.
5. Martínez Martín P, Schapira AH, Stocchi F, Sethi K, Odin P, Macphee G et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623-1629, 2007.
6. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257-1263, 2005.
7. Alves G, Forsaa EB, Pedersen KF, Dreetz GM, Larsen JP. Epidemiology of Parkinson's disease. J Neurol 255(Suppl.5):18-32, 2008.
8. Happe S, Schrodl B, Faltl M, Muller C, Auff E, Zeitlhofer J. Sleep disorders and depression in patients with Parkinson's disease. Acta Neurol Scand 104:275-280, 2001.
9. Happe S, Berger K. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study. J Neurol 248:1062-1067, 2001.
10. Cantor CR, Stern MB. Dopamine agonists and sleep in Parkinson's disease. Neurology 58:S71-S78, 2002.
11. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 12:199-207, 2005.
12. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 67:853-858, 2006.
13. Suzuki K, Miyamoto M, Miyamoto T, Okuma Y, Hattori N, Kamei S et al. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease. Parkinsonism Relat Disord 2008.
14. Verbaan D, Van Rooden SM, Visser M, Marinus J, Van Hilten JJ. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 23:35-41, 2008.
15. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 66:431-435, 1999.
16. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 69:584-589, 2000.
17. Gjerstad MD, Wentzel-Larsen T, Aarsland D, Larsen JP. Insomnia in Parkinson's disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 78:476-479, 2007.
18. Visser M, Verbaan D, Van Rooden S, Marinus J, Van Hilten J, Stiggelbout A. A Longitudinal Evaluation of Health-Related Quality of Life of Patients with Parkinson's Disease. Value Health 2008.
19. Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 255(Suppl.5):33-38, 2008.
20. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8:193-197, 2002.
21. Chaudhuri KR, Pal S, Dimarco A, Whately-Smith C, Bridgman K, Mathew R et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 73:629-635, 2002.
22. Marinus J, Visser M, Van Hilten JJ, Lammers GJ, Stiggelbout AM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049-1054, 2003.
23. Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 21:916-923, 2006.
24. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord 22:1901-1911, 2007.
25. Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson's disease. Age Ageing 35:220-228, 2006.
26. Arnulf I. Sleep and wakefulness disturbances in Parkinson's disease. J Neural Transm Suppl 357-360, 2006.
27. De Cock VC, Vidailhet M, Arnulf I. Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol 4:254-266, 2008.
28. Ondo WG, Dat VK, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57:1392-1396, 2001.
29. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287:455-463, 2002.
30. Comella CL. Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview. J Neural Transm Suppl 349-355, 2006.
31. Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 18:659-667, 2003.
32. Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP et al. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis. Neurology 55:281-288, 2000.
33. Onofrj M, Thomas A, D'Andreamatteo G, Iacono D, Luciano AL, Di Rollo A et al. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Neurol Sci 23(Suppl.2):S91-S94, 2002.
34. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson's disease. J Neurol Sci 196:33-36, 2002.
35. Askenasy JJ. Sleep disturbances in Parkinsonism. J Neural Transm 110:125-150, 2003.
36. Nomura T, Inoue Y, Nakashima K. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease. J Neurol Sci 250:39-44, 2006.
37. Stevens SS. On the theory of the scales and measurement. Science 103:677-680, 1946.
38. Martínez Martín P. Valoración del déficit e incapacidad en la enfermedad de Parkinson. En: Obeso JA, Tolosa E, Grandas F (Eds.). Tratado sobre la enfermedad de Parkinson, 2ª edic. Doyma SA, Barcelona, pp. 303-310, 2000.
39. Hobart J. Rating Scales for neurologists. J Neurol Neurosurg Psychiatry 74(Suppl.4):22-26, 2003.
40. Martínez Martín P, Rodríguez Blázquez C, Frades Payo B. Specific patient reported outcomes measures for Parkinson's disease: analysis and applications. Expert Rev Pharmacoeconomics Outcomes Res 8:401-418, 2008.
41. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use, 3rd edit. Oxford: Oxford University Press, 2003.
42. De Vellis RF. Classical test theory. Med Care 44(Suppl.3):50-59, 2006.
43. Hobart JC, Cano SJ, Zajicek JP, Thompson AJ. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 6:1094-1105, 2007.
44. Martínez Martín P, Salvador C, Menéndez Guisasola L, González S, Tobias A, Almazan J et al. Parkinson's Disease Sleep Scale: validation study of a Spanish version. Mov Disord 19:1226-1232, 2004.
45. Tanasanvimon S, Ayuthaya NI, Phanthumchinda K. Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients. J Med Assoc Thai 90:2277-2283, 2007.
46. Suzuki K, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H et al. Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale. Mov Disord 22:1245-1251, 2007.
47. Wang G, Cheng Q, Zeng J, Bai L, Liu GD, Zhang Y et al. Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale. J Neurol Sci 271:153-157, 2008.
48. Martínez Martín P, Visser M, Rodríguez Blázquez C, Marinus J, Chaudhuri KR, Van Hilten JJ. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 23:1681-1688, 2008.
49. Chaudhuri KR, Martínez Martín P. Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale. Neurology 63:S17-S20, 2004.
50. Pérez LS, Rossi M, Cardinali DP, Merello M. Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson's disease (NMSQuest). Parkinsonism Relat Disord 2008.
51. Martínez Martín P, Cubo Delgado E, Aguilar Barbera M, Bergareche A, Escalante S, Rojo A et al. Estudio piloto sobre una medida específica para los trastornos del sueño de la enfermedad de Parkinson: SCOPA-Sueño. Rev Neurol 43:577-583, 2006.
52. Hjort N, Ostergaard K, Dupont E. Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 19:196-199, 2004.
53. Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands. SCOPA-Sleep Scale. www.scopa-propark.eu/index.php?page=1&nav=1&navRight=3&doc=31&language=nl&taal=nl&docName=SCOPA-SLEEP-NL.pdf&groupName=SCOPA-SLEEP, 2008. Acceso: 14-11-2008.
 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618
Inicio/Home

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008